Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rare Strategic is a private strategic advisory firm focused on the biotechnology sector rather than a drug-development company. The firm was founded by Camilla V. Simpson and provides strategic advice to early-stage, venture-backed biotech companies. Public references describe its work as spanning a wide variety of indications and multiple therapeutic modalities, suggesting a broad advisory scope across life sciences. Rare Strategic appears to operate as a small, specialized consultancy based in Mill Valley, California, and there is no evidence that it maintains an internal therapeutic pipeline or commercial product portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rare Strategic.